作者: M. Susani , L. Kenner , Z. Culig
DOI: 10.1007/S00292-009-1213-5
关键词:
摘要: At present the diagnosis of prostate cancer is carried out by transrectally obtained biopsy samples. The histological findings, value for prostate-specific antigen (PSA) in serum, and clinical stage are objective criteria all subsequent therapy decisions. In over 95% cases an acinar "usual" form diagnosed but can be very different characteristics differentiation. order to correctly assess able select best possible therapeutic measures resulting from diagnosis, information must used a maximum. demands on optimal findings have considerably expanded recent years. It obtain additional biological, molecular genetic material.